You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I: Advanced Microfluidic Devices for Point-of-Care COVID-19 Serological Testing
SBC: Access Sensor Technologies LLC Topic: BMThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project may reach millions of people and provide a key tool in safeguarding the public health through the COVID-19 pandemic. Sensitive, selective and quantitative detection usually requires complex laboratory-based methods and instrumentation to achieve consistent results; however, this project advanc ...
STTR Phase I 2020 National Science Foundation -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
STTR Phase I: Advanced Reaction Control System (RCS) for CubeSat and Microsatellite Platforms
SBC: Maverick Space Systems, Inc. Topic: SPThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to open new orbital flight regimes to CubeSat and microsatellite vehicles. Vehicles of these size classes are currently constrained by the lack of suitable propulsion options or additional regulatory burdens that most propulsion systems levy on rideshare vehicles. Most small satellites in L ...
STTR Phase I 2020 National Science Foundation -
STTR Phase I: AI-assisted Assessment, Tracking, and Reporting of COVID-19 Severity on Chest CT
SBC: AI METRICS, LLC Topic: DHThe broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to leverage artificial intelligence (AI) to reduce errors and improve accuracy, standardization, agreement, and reporting in evaluation of COVID-19 lung disease severity on chest computed tomography (CT) images. Chest CT procedures play a critical role in COVID-19 patients but current meth ...
STTR Phase I 2020 National Science Foundation -
STTR Phase II:Blockchain-Enabled Machine Learning on Confidential Data
SBC: ONAI INC. Topic: OTThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project will enable collaboration with sensitive data. This will increase the ability of companies and institutions in sensitive domains, including biomedicine, to apply existing machine learning models and increase their ability to train new, more sophisticated models, thereby improving insights for ...
STTR Phase II 2020 National Science Foundation -
Marburg Virus Prophylactic Medical Countermeasure
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
STTR Phase I: Development of novel ultrasound-visible percutaneous dilation system
SBC: Perceus, Inc. Topic: MDThis broader impact/commercial potential of this STTR Phase I project is to address certain medical procedures, such as percutaneous nephrolithotomy (PCNL). Currently, one in 11 people develop kidney stones by the age of 70, with a lifetime recurrence rate of 60-80%. PCNL, which involves removal of kidney stones through a surgical channel into the kidney, is the preferred method for stones less th ...
STTR Phase I 2020 National Science Foundation -
STTR Phase I: Development of a Novel Minimally Invasive Reconstruction Device for the Treatment of Male Urethral Stricture Disease
SBC: CELEFLUX LLC Topic: MDThis Small Business Technology Transfer (STTR) Phase I project supports the development of a medical device that enables minimally invasive graft-based reconstruction of the urethra as a long-lasting treatment for male urethral stricture, a class of conditions causing restrictions in flow. Approximately 1% of men on Medicare are treated for stricture annually, and an estimated 1 in 5 men will get ...
STTR Phase I 2020 National Science Foundation -
STTR Phase I: A Roadside Marijuana Breathalyzer to Rapidly Screen for Cannabinoid Sobriety
SBC: SEACOAST SCIENCE, INC. Topic: BTThe broader impact of this Small Business Technology Transfer (STTR) Phase I project will be an affordable, portable breath analysis device to detect marijuana intoxication. First responders, law enforcement, medical professionals, cannabis users, and the general public will benefit from an analytical tool that allows fast and accurate screenings of cannabis impairment. An estimated 37,000 people ...
STTR Phase I 2020 National Science Foundation -
STTR Phase I: COVID-19: AI-based Development of Neutralizing Antibodies for SARS-CoV-2
SBC: PROTABIT, LLC Topic: CTThe broader impact/commercial potential of this STTR project will lead to the development of engineered antibodies for that can be used to provide passive immunity and treatment to patients infected with COVID-19. These neutralizing antibodies can also be administered as preventative measures for populations at high risk of contracting COVID-19. Such engineered antibodies present a wider range of ...
STTR Phase I 2020 National Science Foundation